These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 12031702

  • 1. Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits.
    Matsusaka T, Hasebe N, Jin YT, Kawabe J, Kikuchi K.
    Cardiovasc Res; 2002 Jun; 54(3):568-75. PubMed ID: 12031702
    [Abstract] [Full Text] [Related]

  • 2. Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.
    Miki T, Miura T, Bünger R, Suzuki K, Sakamoto J, Shimamoto K.
    Am J Physiol; 1998 Oct; 275(4):H1329-37. PubMed ID: 9746483
    [Abstract] [Full Text] [Related]

  • 3. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release.
    Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M.
    Circulation; 1994 Mar; 89(3):1237-46. PubMed ID: 8124812
    [Abstract] [Full Text] [Related]

  • 4. Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart.
    Kitakaze M, Minamino T, Funaya H, Node K, Shinozaki Y, Mori H, Hori M.
    Circulation; 1997 Apr 15; 95(8):2108-14. PubMed ID: 9133521
    [Abstract] [Full Text] [Related]

  • 5. Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart.
    Komamura K, Kitakaze M, Funaya H, Ueda Y, Node K, Minamino T, Kurihara T, Hori M.
    J Cardiovasc Pharmacol; 1997 Dec 15; 30(6):775-83. PubMed ID: 9436817
    [Abstract] [Full Text] [Related]

  • 6. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning.
    Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O.
    Cardiovasc Res; 1992 May 15; 26(5):456-61. PubMed ID: 1446315
    [Abstract] [Full Text] [Related]

  • 7. Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels.
    Bai Y, Muqier, Murakami H, Iwasa M, Sumi S, Yamada Y, Ushikoshi H, Aoyama T, Nishigaki K, Takemura G, Uno B, Minatoguchi S.
    Clin Exp Pharmacol Physiol; 2011 Oct 15; 38(10):658-65. PubMed ID: 21679220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Myocardial adenosine formation during hypoxia: effects of ecto-5'-nucleotidase inhibition.
    Headrick JP, Matherne GP, Berne RM.
    J Mol Cell Cardiol; 1992 Mar 15; 24(3):295-303. PubMed ID: 1625350
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes.
    Miura T, Miura T, Kawamura S, Goto M, Sakamoto J, Tsuchida A, Matsuzaki M, Shimamoto K.
    Cardiovasc Res; 1998 Mar 15; 37(3):700-9. PubMed ID: 9659454
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia.
    Zhao ZQ, Nakanishi K, McGee DS, Tan P, Vinten-Johansen J.
    Cardiovasc Res; 1994 Feb 15; 28(2):270-9. PubMed ID: 8143310
    [Abstract] [Full Text] [Related]

  • 15. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism.
    Zhao ZQ, Williams MW, Sato H, Hudspeth DA, McGee DS, Vinten-Johansen J, Van Wylen DG.
    Cardiovasc Res; 1995 Apr 15; 29(4):495-505. PubMed ID: 7796443
    [Abstract] [Full Text] [Related]

  • 16. Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation.
    Zhou Z, de Wijs-Meijler D, Lankhuizen I, Jankowski J, Jankowski V, Jan Danser AH, Duncker DJ, Merkus D.
    Pharmacol Res; 2013 Nov 15; 77():22-9. PubMed ID: 23994209
    [Abstract] [Full Text] [Related]

  • 17. Reserpine attenuates interstitial adenosine-mediated activation of ecto-5'-nucleotidase in rat hearts in vivo.
    Obata T, Yamanaka Y.
    Arch Biochem Biophys; 2000 Mar 15; 375(2):333-9. PubMed ID: 10700389
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine.
    Kin H, Zatta AJ, Lofye MT, Amerson BS, Halkos ME, Kerendi F, Zhao ZQ, Guyton RA, Headrick JP, Vinten-Johansen J.
    Cardiovasc Res; 2005 Jul 01; 67(1):124-33. PubMed ID: 15949476
    [Abstract] [Full Text] [Related]

  • 20. Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity.
    Minamino T, Kitakaze M, Morioka T, Node K, Komamura K, Takeda H, Inoue M, Hori M, Kamada T.
    Am J Physiol; 1996 Jan 01; 270(1 Pt 2):H238-44. PubMed ID: 8769757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.